MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
NDRA ENDRA Life Sciences
- 5.5100
- +0.1400+2.61%
Close Dec 20 16:00 ET
- 5.5100
- 0.00000.00%
Post 16:45 ET
2.96MMarket Cap-0.03P/E (TTM)
6.3000High5.1200Low52.84KVolume5.2900Open5.3700Pre Close301.18KTurnover9.84%Turnover Ratio0.00P/E (Static)536.91KShares4663.750052wk High0.45P/B2.96MFloat Cap4.010052wk Low--Dividend TTM536.82KShs Float205800.0000Historical High--Div YieldTTM21.97%Amplitude4.0100Historical Low5.6990Avg Price1Lot Size
ENDRA Life Sciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 36.23%-1.66M | 8.17%-2.08M | 14.46%-2.14M | 25.22%-9.55M | 29.60%-2.17M | 19.96%-2.6M | 31.98%-2.27M | 19.10%-2.51M | -14.81%-12.77M | -16.43%-3.09M |
| Net income from continuing operations | 24.08%-2.35M | 12.83%-2.23M | 5.68%-2.78M | 23.67%-10.06M | 55.63%-1.46M | 9.87%-3.1M | 28.79%-2.56M | -2.96%-2.94M | -17.34%-13.18M | -5.96%-3.29M |
| Depreciation and amortization | -23.34%54.01K | -31.07%50.12K | -21.63%55.68K | 17.58%275.45K | -9.62%61.25K | 20.24%70.45K | 30.59%72.71K | 36.05%71.04K | 4.39%234.26K | 26.27%67.77K |
| Change In working capital | -229.07%-230.91K | 217.87%47.18K | -16.39%106.67K | 9.99%-923.32K | -648.17%-1.19M | 202.59%178.89K | 63.92%-40.03K | 121.94%127.58K | 18.68%-1.03M | -580.19%-159.02K |
| -Change in inventory | --0 | 719.48%138.05K | -155.75%-231.79K | 91.46%-116.19K | 69.20%-3.28K | --0 | 94.99%-22.28K | 85.96%-90.63K | -95.72%-1.36M | -104.95%-10.64K |
| -Change in prepaid assets | 309.15%353.87K | -0.46%-176.92K | -67.72%42.61K | -52.87%167.36K | 258.98%124.98K | 208.93%86.49K | -177.74%-176.11K | -53.94%132K | 137.10%355.13K | 53.97%-78.61K |
| -Change in payables and accrued expense | -513.44%-540.78K | -34.14%128.97K | 175.15%337.71K | -836.96%-822.26K | -3,524.36%-1.27M | -33.85%130.8K | 40.34%195.81K | 164.40%122.74K | -77.28%111.58K | 6.92%-35.09K |
| -Change in other current liabilities | -14.58%-43.99K | -14.58%-42.91K | -14.58%-41.86K | -15.04%-152.23K | -14.91%-39.85K | -15.08%-38.39K | -15.09%-37.45K | -15.08%-36.53K | -31.88%-132.33K | -15.42%-34.68K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 36.23%-1.66M | 8.17%-2.08M | 14.46%-2.14M | 25.22%-9.55M | 29.60%-2.17M | 19.96%-2.6M | 31.98%-2.27M | 19.10%-2.51M | -14.81%-12.77M | -16.43%-3.09M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 11K | 11.87%-23.8K | 87.80%-24.72K | 105.91%2.28K | 0 | 0 | 69.78%-27K | -350.17%-202.58K | -38.56K |
| Net PPE purchase and sale | --0 | --11K | 11.87%-23.8K | 87.80%-24.72K | 105.91%2.28K | --0 | --0 | 69.78%-27K | -350.17%-202.58K | ---38.56K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --11K | 11.87%-23.8K | 87.80%-24.72K | 105.91%2.28K | --0 | --0 | 69.78%-27K | -350.17%-202.58K | ---38.56K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.85%1.68K | 55.05%7.34M | 468.9K | -10.49%7.52M | 1.67M | 1.11M | -37.28%4.73M | 0 | -37.32%8.4M | 0 |
| Net issuance payments of debt | --0 | --0 | ---28.48K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Net common stock issuance | --0 | -84.54%728.5K | --419.97K | -22.81%6.48M | --656.81K | --1.11M | -37.54%4.71M | --0 | -20.88%8.4M | --0 |
| Proceeds from stock option exercised by employees | --1.68K | 32,861.80%6.61M | --77.42K | --1.03M | --1.01M | --0 | --20.05K | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.85%1.68K | 55.05%7.34M | --468.9K | -10.49%7.52M | --1.67M | --1.11M | -37.28%4.73M | --0 | -37.32%8.4M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 32.81%6.4M | -51.82%1.13M | -42.04%2.83M | -48.33%4.89M | -58.40%3.33M | -57.27%4.82M | -66.95%2.36M | -48.33%4.89M | 30.91%9.46M | -32.03%8.02M |
| Current changes in cash | -11.49%-1.66M | 113.70%5.27M | 32.94%-1.7M | 55.05%-2.06M | 83.99%-500.63K | 54.47%-1.48M | -40.63%2.46M | -8.55%-2.53M | -304.65%-4.57M | -34.12%-3.13M |
| End cash Position | 42.30%4.75M | 32.81%6.4M | -51.82%1.13M | -42.04%2.83M | -42.04%2.83M | -58.40%3.33M | -57.27%4.82M | -66.95%2.36M | -48.33%4.89M | -48.33%4.89M |
| Free cash flow | 36.23%-1.66M | 8.65%-2.07M | 14.31%-2.17M | 26.13%-9.58M | 30.24%-2.18M | 20.32%-2.6M | 33.17%-2.27M | 20.52%-2.53M | -16.16%-12.97M | -17.89%-3.13M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.